NCT00306228View on ClinicalTrials.gov

Role of Tirofiban and the Paclitaxel Eluting Stent in Postfibrinolysis Angioplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

436

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2009

Conditions
Myocardial Infarction
Interventions
PROCEDURE

Postfibrinolysis percutaneous coronary intervention

implantation of a bare-metal stent with no infusion of tirofiban 120 minutes after fibrinolysis

PROCEDURE

Postfibrinolysis percutaneous coronary intervention

implantation of a bare-metal stent with infusion of tirofiban 120 minutes after fibrinolysis

PROCEDURE

Postfibrinolysis percutaneous coronary intervention

implantation of a paclitaxel eluting-stent with no infusion of tirofiban 120 minutes after fibrinolysis

PROCEDURE

Postfibrinolysis percutaneous coronary intervention

implantation of a paclitaxel eluting-stent with infusion of tirofiban 120 minutes after fibrinolysis

Trial Locations (1)

47005

Instituto de Ciencias del Corazón (ICICOR). Hospital Clínico Universitario de Valladolid, Valladolid

Sponsors

Lead Sponsor

GRACIA Group
All Listed Sponsors
collaborator

Spanish Ministry of Health.

UNKNOWN

collaborator

Ministry of Science and Innovation, Spain

OTHER_GOV

lead

GRACIA Group

OTHER